Bad blood: A bone marrow sample from a patient with multiple myeloma, an aggressive blood cancer.
Bone marrow samples from 214 patients (129 males and 85 females) with newly diagnosed MM patients, randomized in the GMMG HD6 trial, were analyzed.
Herein, we discuss the current literature on the interactions of CTCs and DTCs with the immune system, focusing on data generated in analyses of blood and bone marrow samples from patients with cancer.
Submicroscopic evidence of persistent minimal residual disease (MRD) in first remission bone marrow samples from children with acute lymphoblastic leukaemia (ALL) indicates a high risk of clinical relapse.
In 45 previously untreated patients with de novo AML, peripheral blood and/or bone marrow samples from all patients were subjected to microscopic morphologic examination, cytochemical analysis, immunophenotyping and karyotyping.
Diagnostic peripheral blood or bone marrow samples from NPM1-mutated AML patients (n = 120) were subjected to targeted sequencing using a panel of fifty-seven genes known to be commonly mutated in myeloid malignancies.
We examined the pre-treatment bone marrow samples from 200 consecutive adult patients with acute lymphoblastic leukemia (ALL) treated on various protocols at the University of Texas, M.D. Anderson Cancer Center between 1986 and 1998.
Dr. Sykes, a professor at Columbia, led the team there and at Massachusetts General Hospital that replicated an individual's immune system in mice using a bone marrow sample from the person's hip.
The core also collects and stores follow-up blood and bone marrow samples from subjects treated on protocols that the core produced components for, thus providing an additional service to clinical investigators beyond what cell manufacturing laboratories provide, ensuring that all research objectives of clinical protocols are met.
First they gathered bone marrow samples from 59 patients at different stages of the disease.
BP1 expression was investigated in bone marrow samples from acute myeloid leukemia (AML), acute T cell lymphocytic leukemia (ALL) and pre-B cell ALL.
